Hence, we do not reject the hypothesis of CIN resulting from RB1 or CDKN2A loss in our experimental setup, but we can conclude that there is a major difference between how cells lacking either RB1, CDKN2A or TP53 manifest as new clones. The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.